323 related articles for article (PubMed ID: 33477990)
1. Dermatological Manifestations in Inflammatory Bowel Diseases.
Antonelli E; Bassotti G; Tramontana M; Hansel K; Stingeni L; Ardizzone S; Genovese G; Marzano AV; Maconi G
J Clin Med; 2021 Jan; 10(2):. PubMed ID: 33477990
[TBL] [Abstract][Full Text] [Related]
2. Dermatological Manifestations in Pediatric Inflammatory Bowel Disease.
Diaconescu S; Strat S; Balan GG; Anton C; Stefanescu G; Ioniuc I; Stanescu AMA
Medicina (Kaunas); 2020 Aug; 56(9):. PubMed ID: 32842528
[TBL] [Abstract][Full Text] [Related]
3. Management of cutaneous disorders related to inflammatory bowel disease.
Pellicer Z; Santiago JM; Rodriguez A; Alonso V; Antón R; Bosca MM
Ann Gastroenterol; 2012; 25(1):21-26. PubMed ID: 24713996
[TBL] [Abstract][Full Text] [Related]
4. The Risk of Later Diagnosis of Inflammatory Bowel Disease in Patients With Dermatological Disorders Associated With Inflammatory Bowel Disease.
King D; Chandan JS; Thomas T; Nirantharakumar K; Reulen RC; Adderley NJ; Trudgill N
Inflamm Bowel Dis; 2021 Oct; 27(11):1731-1739. PubMed ID: 34669933
[TBL] [Abstract][Full Text] [Related]
5. Cutaneous manifestations in inflammatory bowel diseases: eight cases of psoriasis induced by anti-tumor-necrosis-factor antibody therapy.
Passarini B; Infusino SD; Barbieri E; Varotti E; Gionchetti P; Rizzello F; Morselli C; Tambasco R; Campieri M
Dermatology; 2007; 215(4):295-300. PubMed ID: 17911986
[TBL] [Abstract][Full Text] [Related]
6. Mucocutaneous Manifestations of Inflammatory Bowel Disease.
Alvarez-Payares JC; Ramírez-Urrea S; Correa-Parra L; Salazar-Uribe D; Velásquez-López M
Cureus; 2021 Aug; 13(8):e17191. PubMed ID: 34548985
[TBL] [Abstract][Full Text] [Related]
7. Cutaneous manifestations of gastrointestinal disease: part II.
Thrash B; Patel M; Shah KR; Boland CR; Menter A
J Am Acad Dermatol; 2013 Feb; 68(2):211.e1-33; quiz 244-6. PubMed ID: 23317981
[TBL] [Abstract][Full Text] [Related]
8. [Cutaneous involvement in chronic inflammatory bowel disease : Crohn's disease and ulcerative colitis].
Richter L; Rappersberger K
Hautarzt; 2016 Dec; 67(12):940-947. PubMed ID: 27830291
[TBL] [Abstract][Full Text] [Related]
9. [Cutaneous and mucosal manifestations of inflammatory bowel diseases].
Károlyi Z; Erós N; Ujszászy L; Nagy G
Orv Hetil; 2000 Jun; 141(25):1391-5. PubMed ID: 10934882
[TBL] [Abstract][Full Text] [Related]
10. [The role of biologic therapy in the treatment of extraintestinal manifestations and complications of inflammatory bowel disease].
Kujundzić M
Acta Med Croatica; 2013 Apr; 67(2):195-201. PubMed ID: 24471303
[TBL] [Abstract][Full Text] [Related]
11. Cutaneous manifestations in 404 Iranian patients with inflammatory bowel disease: a retrospective study.
Moravvej H; Razavi GM; Farshchian M; Malekzadeh R
Indian J Dermatol Venereol Leprol; 2008; 74(6):607-10. PubMed ID: 19171983
[TBL] [Abstract][Full Text] [Related]
12. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
[TBL] [Abstract][Full Text] [Related]
13. Review article: skin complications associated with inflammatory bowel disease.
Tavarela Veloso F
Aliment Pharmacol Ther; 2004 Oct; 20 Suppl 4():50-3. PubMed ID: 15352894
[TBL] [Abstract][Full Text] [Related]
14. Biological therapy for dermatological manifestations of inflammatory bowel disease.
Zippi M; Pica R; De Nitto D; Paoluzi P
World J Clin Cases; 2013 May; 1(2):74-8. PubMed ID: 24303470
[TBL] [Abstract][Full Text] [Related]
15. Dermatologic manifestations in inflammatory bowel disease in Tunisia.
Mebazaa A; Aounallah A; Naija N; Cheikh Rouhou R; Kallel L; El Euch D; Boubaker J; Mokni M; Filali A; Ben Osman A
Tunis Med; 2012 Mar; 90(3):252-7. PubMed ID: 22481199
[TBL] [Abstract][Full Text] [Related]
16. Pyostomatitis vegetans (PSV)-pyodermatitis vegetans (PDV): A clinicopathologic study of 7 cases at a tertiary referral center.
Clark LG; Tolkachjov SN; Bridges AG; Camilleri MJ
J Am Acad Dermatol; 2016 Sep; 75(3):578-584. PubMed ID: 27349819
[TBL] [Abstract][Full Text] [Related]
17. Skin gangrene as an extraintestinal manifestation of inflammatory bowel disease.
Komatsu YC; Capareli GC; Boin MF; Lellis R; Freitas TH; Simone K
An Bras Dermatol; 2014; 89(6):967-9. PubMed ID: 25387503
[TBL] [Abstract][Full Text] [Related]
18. Ustekinumab for the treatment of paradoxical skin reactions and cutaneous manifestations of inflammatory bowel diseases.
Wu J; Smogorzewski J
Dermatol Ther; 2021 May; 34(3):e14883. PubMed ID: 33594811
[TBL] [Abstract][Full Text] [Related]
19. Successful treatment of ulcerative colitis complicated by Sweet's syndrome by corticosteroid therapy and leukocytapheresis.
Terai T; Sugimoto M; Osawa S; Sugimoto K; Furuta T; Kanaoka S; Ikuma M
Clin J Gastroenterol; 2011 Jun; 4(3):151-156. PubMed ID: 26189346
[TBL] [Abstract][Full Text] [Related]
20. Cutaneous manifestations in patients with inflammatory bowel diseases: pathophysiology, clinical features, and therapy.
Marzano AV; Borghi A; Stadnicki A; Crosti C; Cugno M
Inflamm Bowel Dis; 2014 Jan; 20(1):213-27. PubMed ID: 24105394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
